Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer
Clinical trial NCT05387109 · UNKNOWN
Trial details
- NCT number
- NCT05387109
- Sponsor
- Tang-Du Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2023-04-20
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.